EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

6-Phosphogluconate dehydrogenase promotes glycolysis and fatty acid synthesis by inhibiting the AMPK pathway in lung adenocarcinoma cells

Jun Wu, Yong Chen, Hui Zou, Kaiyue Xu, Jiaqi Hou, Mengmeng Wang, Shuyu Tian, Mingjun Gao, Qinglin Ren, Chao Sun, Shichun Lu, Qiang Wang und 3 weitere

Cancer Letters · 2024

DOI: 10.1016/j.canlet.2024.217177 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2024. Verfasst von Jun Wu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Medical College, Yangzhou University, Yangzhou, China; Department of Thoracic Surgery, Northern Jiangsu People's Hospital, Yangzhou, China; Yangzhou …. Hauptthemen laut MEDLINE: Phosphogluconate Dehydrogenase, Adenocarcinoma of Lung, Lung Neoplasms, Glycolysis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Abnormal metabolism has emerged as a prominent hallmark of cancer and plays a pivotal role in carcinogenesis and progression of lung adenocarcinoma (LUAD). In this study, single-cell sequencing revealed that the metabolic enzyme 6-phosphogluconate dehydrogenase (PGD), which is a critical regulator of the pentose phosphate pathway (PPP), is significantly upregulated in the malignant epithelial cell subpopulation during malignant progression. However, the precise functional significance of PGD in LUAD and its underlying mechanisms remain elusive. Through the integration of TCGA database analysis and LUAD tissue microarray data, it was found that PGD expression was significantly upregulated in LUAD and closely correlated with a poor prognosis in LUAD patients. Moreover, in vitro and in vivo analyses demonstrated that PGD knockout and inhibition of its activity mitigated the proliferation, migration, and invasion of LUAD cells. Mechanistically, immunoprecipitation-mass spectrometry (IP-MS) revealed for the first time that IQGAP1 is a robust novel interacting protein of PGD. PGD decreased p-AMPK levels by competitively interacting with the IQ domain of the known AMPKα binding partner IQGAP1, which promoted glycolysis and fatty acid synthesis in LUAD cells. Furthermore, we demonstrated that the combination of Physcion (a PGD-specific inhibitor) and metformin (an AMPK agonist) could inhibit tumor growth more effectively both in vivo and in vitro. Collectively, these findings suggest that PGD is a potential prognostic biomarker and therapeutic target for LUAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phosphogluconate DehydrogenaseAdenocarcinoma of LungLung NeoplasmsGlycolysisFatty AcidsAMP-Activated Protein KinasesHumansAnimalsMiceCell Line, TumorCell ProliferationFemaleSignal TransductionMaleMice, NudePrognosisXenograft Model Antitumor AssaysGene Expression Regulation, NeoplasticCell Movement

Stichwörter der Autor:innen

6-Phosphogluconate dehydrogenaseAMPK pathwayLung adenocarcinomaPentose phosphate pathwaySingle-cell sequencing

Substanzen

Phosphogluconate DehydrogenaseFatty AcidsAMP-Activated Protein Kinases

Autor:innen und Institutionen

  • Medical College, Yangzhou University, Yangzhou, China; Department of Thoracic Surgery, Northern Jiangsu People's Hospital, Yangzhou, China; Yangzhou Key Laboratory of Thoracic and Cardiac Surgery, Yangzhou, China.
  • Department of Thoracic Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
  • The Yangzhou School of Clinical Medicine of Nanjing Medical University, Yangzhou, China; Department of Thoracic Surgery, Northern Jiangsu People's Hospital, Yangzhou, China.
  • Department of Radiation Oncology, Suzhou Municipal Hospital, Suzhou, China.
  • First College of Clinical Medicine, Dalian Medical University, Dalian, China.
  • Department of Thoracic Surgery, Northern Jiangsu People's Hospital, Yangzhou, China.

Zitieren

APA

Wu, J., Chen, Y., Zou, H., Xu, K., Hou, J., Wang, M., Tian, S., Gao, M., Ren, Q., Sun, C., Lu, S., Wang, Q., Shu, Y., Wang, S., & Wang, X. (2024). 6-Phosphogluconate dehydrogenase promotes glycolysis and fatty acid synthesis by inhibiting the AMPK pathway in lung adenocarcinoma cells. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.217177

Vancouver

Wu J, Chen Y, Zou H, Xu K, Hou J, Wang M, et al. 6-Phosphogluconate dehydrogenase promotes glycolysis and fatty acid synthesis by inhibiting the AMPK pathway in lung adenocarcinoma cells. Cancer Letters. 2024. doi:10.1016/j.canlet.2024.217177

BibTeX
@article{Wu2024,
  author = {Wu, Jun and Chen, Yong and Zou, Hui and Xu, Kaiyue and Hou, Jiaqi and Wang, Mengmeng and Tian, Shuyu and Gao, Mingjun and Ren, Qinglin and Sun, Chao and Lu, Shichun and Wang, Qiang and Shu, Yusheng and Wang, Shouyu and Wang, Xiaolin},
  title = {6-Phosphogluconate dehydrogenase promotes glycolysis and fatty acid synthesis by inhibiting the AMPK pathway in lung adenocarcinoma cells},
  journal = {Cancer Letters},
  year = {2024},
  doi = {10.1016/j.canlet.2024.217177}
}
Kostenlos starten →